Use of sodium 4-phenylbutyrate to define therapeutic parameters for reducing intracerebral hemorrhage and myopathy in Col4a1 mutant mice
Collagen type IV alpha 1 (COL4A1) and alpha 2 (COL4A2) form heterotrimers that constitute a major component of nearly all basement membranes. COL4A1 and COL4A2 mutations cause a multisystem disorder that includes variable cerebrovascular and skeletal muscle manifestations. The pathogenicity of COL4A...
Main Authors: | Genki Hayashi, Cassandre Labelle-Dumais, Douglas B. Gould |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2018-07-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/11/7/dmm034157 |
Similar Items
-
COL6A1 mutation leading to Bethlem myopathy with recurrent hematuria: a case report
by: Mengxin Bao, et al.
Published: (2019-02-01) -
Genotype-phenotype correlation of the childhood-onset bethlem myopathy in the mediterranean region of Turkey
by: Muhammet G Kutluk, et al.
Published: (2021-01-01) -
Collagen IV (COL4A1, COL4A2), a Component of the Viral Biofilm, Is Induced by the HTLV-1 Oncoprotein Tax and Impacts Virus Transmission
by: Sebastian Millen, et al.
Published: (2019-10-01) -
A novel de novo COL6A1 mutation emphasizes the role of intron 14 donor splice site defects as a cause of moderate-progressive form of ColVI myopathy – a case report and review of the genotype–phenotype correlation
by: Agnieszka A. Koppolu, et al.
Published: (2017-09-01) -
A novel variant in the COL6A1 gene causing Ullrich congenital muscular dystrophy in a consanguineous family: a case report
by: Nirmala Dushyanthi Sirisena, et al.
Published: (2021-03-01)